Large-Cap & Specialty Pharmaceuticals — multiples
Median EV / LTM Revenue across the cohort at each month end, with the 25th–75th percentile band. Membership follows the same tagging as the company counts, so a company tagged into several subsectors is included in each.
Historical median multiple
Large-Cap & Specialty Pharmaceuticals · Median EV / LTM Revenue
Cross-sectional median multiple over time, with the 25th–75th percentile range shaded.
Current
2.7x
Median
1.9x
Min
1.5x
Max
2.7x
Latest point 2026-08-04: median 2.7x across 2 companies.
Other subsectors in Pharma & Biotech
Biotechnology
Clinical-stage biotech; commercial-stage biotech; platform biotech; biologics; cell/gene therapy.
1
Generic, Biosimilar & Contract Pharma
Generics; biosimilars; CDMOs; active pharmaceutical ingredients; drug delivery/manufacturing.
0
Life-Sciences Tools & Services
CROs; clinical research; bioinformatics/data; drug discovery services; laboratory services.
0
Animal Health
Veterinary pharmaceuticals; animal vaccines; companion-animal diagnostics; livestock health.
0